GXR RM China BE Study (Darmstadt - Jiangsu)
Clinical trial NCT05463094 · COMPLETED
Trial details
- NCT number
- NCT05463094
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-25
- Primary completion
- 2023-01-03
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.